Studies on veterinary medicinal products that already have a marketing authorisation” within the meaning of 6° of article L. 5141-16, hereinafter referred to as “post-authorisation studies”, means studies carried out under the responsibility of the marketing authorisation holder, as referred to in article L. 5141-5, who manages them, or under the responsibility of the operator, as defined in article R. 5142-1, and falling into one of the following categories 5141-5, who manages them, or under the responsibility of the operator, as defined in article R. 5142-1, and falling into one of the following categories:
1° “Post-marketing surveillance studies” as defined in 6° of article R. 5141-92;
2° Safety trials, including trials assessing the risk to the environment, residue studies and pre-clinical trials, as well as clinical trials relating to veterinary medicinal products already benefiting from a marketing authorisation and which are not carried out with a view to amending the marketing authorisation.